Singapore markets open in 6 hours 29 minutes

UroGen Pharma Ltd. (URGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.99-0.19 (-1.11%)
As of 02:29PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
84,302
82,713
64,357
48,042
11,799
-
Cost of revenue
8,824
9,361
7,654
5,157
1,009
-
Gross profit
75,478
73,352
56,703
42,885
10,790
-
Operating expenses
Research development
48,610
45,614
52,906
47,642
47,310
-
Selling general and administrative
96,099
93,274
82,838
87,535
90,219
-
Total operating expenses
144,709
138,888
135,744
135,177
137,529
-
Operating income or loss
-69,231
-65,536
-79,041
-92,292
-126,739
-
Interest expense
13,609
14,715
8,438
0
-
-
Total other income/expenses net
-284
-20,714
-21,487
-17,291
-
-284
Income before tax
-100,364
-98,324
-108,028
-109,371
-125,110
-
Income tax expense
3,953
3,920
1,755
1,449
3,374
-
Income from continuing operations
-104,317
-102,244
-109,783
-110,820
-128,484
-
Net income
-104,317
-102,244
-109,783
-110,820
-128,484
-
Net income available to common shareholders
-104,317
-102,244
-109,783
-110,820
-128,484
-
Basic EPS
-4.14
-
-4.79
-4.96
-5.90
-5.12
Diluted EPS
-4.14
-
-4.79
-4.96
-5.90
-5.12
Basic average shares
25,542
-
22,807
22,347
21,781
20,529
Diluted average shares
25,542
-
22,807
22,347
21,781
20,529